Earnings Outlook For Dare Bioscience
Portfolio Pulse from Benzinga Insights
Dare Bioscience (NASDAQ:DARE) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $0.72, down 37.33% over the last 52-week period.
August 09, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Dare Bioscience is expected to report an EPS of $-0.10. Despite beating EPS estimates in the past, the company's share price has typically dropped. The stock is currently down 37.33% over the last 52 weeks.
The company has a history of beating EPS estimates but this has not translated into a rise in share price. Given the negative returns over the past year, investors are likely to be bearish going into this earnings release.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100